US20240018228A1

Antibodies specific to ccl21 and methods of use

University of Texas System

Abstract

Disclosed herein are anti-CCL21 antibodies useful in treating autoimmune diseases, treating or preventing allograft transplant rejection, and treating metastatic cancer or preventing cancer metastasis in a subject.

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Robert Hromas
Priority date: August 28, 2020
Filing date: August 27, 2021
Publication date: January 18, 2024
Language: en
PDF source: https://patentimages.storage.googleapis.com/78/e6/6a/2013b910397c6d/US20240018228A1.pdf
Metadata fetched: August 29, 2026 00:32